Ninlaro 3 MG Oral Capsule
- RxCUI
- 1723767
- RxNorm name
- Ninlaro 3 MG Oral Capsule
- Display name
- Ninlaro 3 MG Oral Capsule
- Full name
- Ninlaro 3 MG Oral Capsule
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:46
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NINLARO | IXAZOMIB | Takeda Pharmaceuticals America, Inc. | 038f2461-834b-4488-9ebd-863c83eef5a7 | 2025-08-18 | Warnings, Adverse reactions | 1723767 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 038f2461-834b-4488-9ebd-863c83eef5a7 | Ninlaro 3 MG Oral Capsule | SY | 16 | These highlights do not include all the information needed to use NINLARO safely and effectively. See full prescribing information for NINLARO. NINLARO ® (ixazomib) capsules, for oral use Initial U.S. Approval: 2015 | 20250818 |
| 038f2461-834b-4488-9ebd-863c83eef5a7 | NINLARO 3 MG Oral Capsule | PSN | 16 | These highlights do not include all the information needed to use NINLARO safely and effectively. See full prescribing information for NINLARO. NINLARO ® (ixazomib) capsules, for oral use Initial U.S. Approval: 2015 | 20250818 |
| 038f2461-834b-4488-9ebd-863c83eef5a7 | ixazomib 3 MG Oral Capsule [Ninlaro] | SBD | 16 | These highlights do not include all the information needed to use NINLARO safely and effectively. See full prescribing information for NINLARO. NINLARO ® (ixazomib) capsules, for oral use Initial U.S. Approval: 2015 | 20250818 |
| 038f2461-834b-4488-9ebd-863c83eef5a7 | Ninlaro 3 MG (as ixazomib citrate 4.3 MG) Oral Capsule | SY | 16 | These highlights do not include all the information needed to use NINLARO safely and effectively. See full prescribing information for NINLARO. NINLARO ® (ixazomib) capsules, for oral use Initial U.S. Approval: 2015 | 20250818 |